Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Bleeding behind the eye.

Risheim H, Sneve M.

Tidsskr Nor Laegeforen. 2014 Oct 14;134(19):1854. doi: 10.4045/tidsskr.13.0712. eCollection 2014 Oct 14. English, Norwegian. No abstract available.

2.

Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø.

Jorde R, Strand Hutchinson M, Kjærgaard M, Sneve M, Grimnes G.

ISRN Endocrinol. 2013;2013:348705. doi: 10.1155/2013/348705. Epub 2013 Mar 14.

3.

Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects.

Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E.

Cytokine. 2012 Dec;60(3):870-4. doi: 10.1016/j.cyto.2012.07.032. Epub 2012 Aug 24.

PMID:
22925537
4.

Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed.

Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, Hutchinson MS, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R.

Eur J Endocrinol. 2010 Aug;163(2):339-48. doi: 10.1530/EJE-10-0150. Epub 2010 May 17. Erratum in: Eur J Endocrinol. 2010 Dec;163(6):965.

PMID:
20479012
5.

Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study.

Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G.

Am J Epidemiol. 2010 Apr 15;171(8):903-8. doi: 10.1093/aje/kwq005. Epub 2010 Mar 10.

PMID:
20219763
6.

Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study.

Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G.

Eur J Nutr. 2010 Oct;49(7):401-7. doi: 10.1007/s00394-010-0098-7. Epub 2010 Mar 4.

PMID:
20204652
7.

No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects.

Jorde R, Sneve M, Torjesen PA, Figenschau Y, Gøransson LG, Omdal R.

Cytokine. 2010 May;50(2):175-80. doi: 10.1016/j.cyto.2009.12.006. Epub 2010 Feb 1.

PMID:
20122848
8.

Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D.

Jorde R, Sneve M, Torjesen P, Figenschau Y, Hansen JB.

Thromb Res. 2010 May;125(5):e210-3. doi: 10.1016/j.thromres.2009.12.011. Epub 2010 Jan 13.

PMID:
20071011
9.

No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.

Jorde R, Sneve M, Torjesen PA, Figenschau Y, Hansen JB, Grimnes G.

Nutr J. 2010 Jan 7;9:1. doi: 10.1186/1475-2891-9-1.

10.

Bone mineral density at the hip in Norwegian women and men--prevalence of osteoporosis depends on chosen references: the Tromsø Study.

Emaus N, Omsland TK, Ahmed LA, Grimnes G, Sneve M, Berntsen GK.

Eur J Epidemiol. 2009;24(6):321-8. doi: 10.1007/s10654-009-9333-z. Epub 2009 Mar 19.

PMID:
19296062
11.

The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study.

Sneve M, Emaus N, Joakimsen RM, Jorde R.

Eur J Endocrinol. 2008 Mar;158(3):401-9. doi: 10.1530/EJE-07-0610.

PMID:
18299475

Supplemental Content

Loading ...
Support Center